#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Natural Antimicrobials from Bacteria and Viruses :
1-1	0-2	4.	_	_	_	_
1-2	3-10	Natural	substance[1]	new[1]	_	_
1-3	11-25	Antimicrobials	substance[1]	new[1]	_	_
1-4	26-30	from	substance[1]	new[1]	_	_
1-5	31-39	Bacteria	substance[1]|substance|abstract[3]	new[1]|new|new[3]	coref|coref	6-7[15_0]|23-22[196_3]
1-6	40-43	and	substance[1]|abstract[3]	new[1]|new[3]	_	_
1-7	44-51	Viruses	substance[1]|abstract[3]|place	new[1]|new[3]|new	_	_
1-8	52-53	:	_	_	_	_

#Text=Biopreservation
2-1	54-69	Biopreservation	abstract	new	coref	3-1

#Text=Biopreservation is defined as “ the use of microorganisms ( including bacteriophages ) , their metabolic products , or both to preserve foods that are not generally considered fermented ” .
3-1	70-85	Biopreservation	abstract	giv	coref	7-6
3-2	86-88	is	_	_	_	_
3-3	89-96	defined	_	_	_	_
3-4	97-99	as	_	_	_	_
3-5	100-101	“	_	_	_	_
3-6	102-105	the	_	_	_	_
3-7	106-109	use	_	_	_	_
3-8	110-112	of	_	_	_	_
3-9	113-127	microorganisms	animal	new	ana	3-15
3-10	128-129	(	_	_	_	_
3-11	130-139	including	_	_	_	_
3-12	140-154	bacteriophages	substance	new	_	_
3-13	155-156	)	_	_	_	_
3-14	157-158	,	_	_	_	_
3-15	159-164	their	animal	giv	_	_
3-16	165-174	metabolic	_	_	_	_
3-17	175-183	products	_	_	_	_
3-18	184-185	,	_	_	_	_
3-19	186-188	or	_	_	_	_
3-20	189-193	both	_	_	_	_
3-21	194-196	to	_	_	_	_
3-22	197-205	preserve	_	_	_	_
3-23	206-211	foods	substance	new	coref	17-9
3-24	212-216	that	_	_	_	_
3-25	217-220	are	_	_	_	_
3-26	221-224	not	_	_	_	_
3-27	225-234	generally	_	_	_	_
3-28	235-245	considered	_	_	_	_
3-29	246-255	fermented	_	_	_	_
3-30	256-257	”	_	_	_	_
3-31	258-259	.	_	_	_	_

#Text=4.1 .
4-1	260-263	4.1	abstract	new	_	_
4-2	264-265	.	_	_	_	_

#Text=Controlled Acidification
5-1	266-276	Controlled	substance[12]	new[12]	coref	12-50[0_12]
5-2	277-290	Acidification	substance[12]	new[12]	_	_

#Text=The production of acid by lactic acid bacteria ( LAB ) under controlled acidification conditions is a preservation form very important in food production ; the pH of the food , the characteristics of the targeted microorganism , the fermented carbohydrate that is going to be used by the biopreservatives , the LAB growth kinetics , the temperature ( refrigeration or abuse ) , and the targeted pathogens are factors to be taken into account .
6-1	291-294	The	abstract[13]	new[13]	coref	6-17[20_13]
6-2	295-305	production	abstract[13]	new[13]	_	_
6-3	306-308	of	abstract[13]	new[13]	_	_
6-4	309-313	acid	abstract[13]|substance[14]	new[13]|new[14]	coref	7-39[0_14]
6-5	314-316	by	abstract[13]|substance[14]	new[13]|new[14]	_	_
6-6	317-323	lactic	abstract[13]|substance[14]	new[13]|new[14]	_	_
6-7	324-328	acid	abstract[13]|substance[14]|substance[15]	new[13]|new[14]|giv[15]	coref	12-1[87_15]
6-8	329-337	bacteria	abstract[13]|substance[14]|substance[15]	new[13]|new[14]|giv[15]	_	_
6-9	338-339	(	_	_	_	_
6-10	340-343	LAB	object	new	coref	6-53
6-11	344-345	)	_	_	_	_
6-12	346-351	under	_	_	_	_
6-13	352-362	controlled	abstract[18]	new[18]	coref	9-26[76_18]
6-14	363-376	acidification	abstract|abstract[18]	new|new[18]	_	_
6-15	377-387	conditions	abstract[18]	new[18]	_	_
6-16	388-390	is	_	_	_	_
6-17	391-392	a	abstract[20]	giv[20]	coref	6-23[22_20]
6-18	393-405	preservation	abstract|abstract[20]	new|giv[20]	_	_
6-19	406-410	form	abstract[20]	giv[20]	_	_
6-20	411-415	very	_	_	_	_
6-21	416-425	important	_	_	_	_
6-22	426-428	in	_	_	_	_
6-23	429-433	food	substance|abstract[22]	new|giv[22]	appos|coref	6-26[23_22]|6-29[24_0]
6-24	434-444	production	abstract[22]	giv[22]	_	_
6-25	445-446	;	_	_	_	_
6-26	447-450	the	abstract[23]	giv[23]	coref	7-27[0_23]
6-27	451-453	pH	abstract[23]	giv[23]	_	_
6-28	454-456	of	abstract[23]	giv[23]	_	_
6-29	457-460	the	abstract[23]|substance[24]	giv[23]|giv[24]	coref	7-36[49_24]
6-30	461-465	food	abstract[23]|substance[24]	giv[23]|giv[24]	_	_
6-31	466-467	,	abstract[23]	giv[23]	_	_
6-32	468-471	the	abstract[23]	giv[23]	_	_
6-33	472-487	characteristics	abstract[23]	giv[23]	_	_
6-34	488-490	of	abstract[23]	giv[23]	_	_
6-35	491-494	the	abstract[23]|object[25]	giv[23]|new[25]	_	_
6-36	495-503	targeted	abstract[23]|object[25]	giv[23]|new[25]	_	_
6-37	504-517	microorganism	abstract[23]|object[25]	giv[23]|new[25]	_	_
6-38	518-519	,	abstract[23]	giv[23]	_	_
6-39	520-523	the	abstract[23]|substance[26]	giv[23]|new[26]	coref	7-45[54_26]
6-40	524-533	fermented	abstract[23]|substance[26]	giv[23]|new[26]	_	_
6-41	534-546	carbohydrate	abstract[23]|substance[26]	giv[23]|new[26]	_	_
6-42	547-551	that	_	_	_	_
6-43	552-554	is	_	_	_	_
6-44	555-560	going	_	_	_	_
6-45	561-563	to	_	_	_	_
6-46	564-566	be	_	_	_	_
6-47	567-571	used	_	_	_	_
6-48	572-574	by	_	_	_	_
6-49	575-578	the	substance[27]	new[27]	_	_
6-50	579-595	biopreservatives	substance[27]	new[27]	_	_
6-51	596-597	,	_	_	_	_
6-52	598-601	the	abstract[30]	new[30]	_	_
6-53	602-605	LAB	object|abstract[30]	giv|new[30]	coref	7-4[39_0]
6-54	606-612	growth	abstract|abstract[30]	new|new[30]	coref	17-22[142_0]
6-55	613-621	kinetics	abstract[30]	new[30]	_	_
6-56	622-623	,	_	_	_	_
6-57	624-627	the	quantity[31]	new[31]	appos	6-60[33_31]
6-58	628-639	temperature	quantity[31]	new[31]	_	_
6-59	640-641	(	_	_	_	_
6-60	642-655	refrigeration	substance|quantity[33]	new|giv[33]	_	_
6-61	656-658	or	quantity[33]	giv[33]	_	_
6-62	659-664	abuse	quantity[33]|event	giv[33]|new	coref	9-28
6-63	665-666	)	_	_	_	_
6-64	667-668	,	_	_	_	_
6-65	669-672	and	_	_	_	_
6-66	673-676	the	abstract[35]	new[35]	coref	6-70[0_35]
6-67	677-685	targeted	abstract[35]	new[35]	_	_
6-68	686-695	pathogens	abstract[35]	new[35]	_	_
6-69	696-699	are	_	_	_	_
6-70	700-707	factors	abstract	giv	coref	14-31[120_0]
6-71	708-710	to	_	_	_	_
6-72	711-713	be	_	_	_	_
6-73	714-719	taken	_	_	_	_
6-74	720-724	into	_	_	_	_
6-75	725-732	account	abstract	new	_	_
6-76	733-734	.	_	_	_	_

#Text=The use of LAB for biopreservation comes back to the 1950s for preventing the production of botulinum toxin ; Clostridium botulinum is unable to grow at pH < 4.6 , so LAB is added to the food for acid production after the use of a fermentable carbohydrate also added to it and , consequently , the pH decreases .
7-1	735-738	The	abstract[38]	new[38]	_	_
7-2	739-742	use	abstract[38]	new[38]	_	_
7-3	743-745	of	abstract[38]	new[38]	_	_
7-4	746-749	LAB	abstract[38]|object[39]	new[38]|giv[39]	coref	7-32[0_39]
7-5	750-753	for	abstract[38]|object[39]	new[38]|giv[39]	_	_
7-6	754-769	biopreservation	abstract[38]|object[39]|substance	new[38]|giv[39]|giv	_	_
7-7	770-775	comes	_	_	_	_
7-8	776-780	back	_	_	_	_
7-9	781-783	to	_	_	_	_
7-10	784-787	the	time[41]	new[41]	_	_
7-11	788-793	1950s	time[41]	new[41]	_	_
7-12	794-797	for	_	_	_	_
7-13	798-808	preventing	_	_	_	_
7-14	809-812	the	abstract[42]	new[42]	coref	7-39[51_42]
7-15	813-823	production	abstract[42]	new[42]	_	_
7-16	824-826	of	abstract[42]	new[42]	_	_
7-17	827-836	botulinum	abstract[42]|substance|object[44]	new[42]|new|new[44]	coref	7-20[45_0]
7-18	837-842	toxin	abstract[42]|object[44]	new[42]|new[44]	_	_
7-19	843-844	;	_	_	_	_
7-20	845-856	Clostridium	substance[45]	giv[45]	_	_
7-21	857-866	botulinum	substance[45]	giv[45]	_	_
7-22	867-869	is	_	_	_	_
7-23	870-876	unable	_	_	_	_
7-24	877-879	to	_	_	_	_
7-25	880-884	grow	abstract|abstract	new|new	coref|coref|none|none	19-25[159_0]|20-4[163_0]|7-25[0_159]|7-25[0_163]
7-26	885-887	at	_	_	_	_
7-27	888-890	pH	abstract	giv	coref	7-56[56_0]
7-28	891-892	<	_	_	_	_
7-29	893-896	4.6	quantity	new	_	_
7-30	897-898	,	_	_	_	_
7-31	899-901	so	_	_	_	_
7-32	902-905	LAB	object	giv	coref	13-18[108_0]
7-33	906-908	is	_	_	_	_
7-34	909-914	added	_	_	_	_
7-35	915-917	to	_	_	_	_
7-36	918-921	the	substance[49]	giv[49]	coref	12-38[97_49]
7-37	922-926	food	substance[49]	giv[49]	_	_
7-38	927-930	for	substance[49]	giv[49]	_	_
7-39	931-935	acid	substance[49]|substance|abstract[51]	giv[49]|giv|giv[51]	coref	8-12
7-40	936-946	production	substance[49]|abstract[51]	giv[49]|giv[51]	_	_
7-41	947-952	after	_	_	_	_
7-42	953-956	the	abstract[52]	new[52]	ana	7-51[0_52]
7-43	957-960	use	abstract[52]	new[52]	_	_
7-44	961-963	of	abstract[52]	new[52]	_	_
7-45	964-965	a	abstract[52]|substance[54]	new[52]|giv[54]	_	_
7-46	966-977	fermentable	abstract[52]|abstract|substance[54]	new[52]|new|giv[54]	_	_
7-47	978-990	carbohydrate	abstract[52]|substance[54]	new[52]|giv[54]	_	_
7-48	991-995	also	_	_	_	_
7-49	996-1001	added	_	_	_	_
7-50	1002-1004	to	_	_	_	_
7-51	1005-1007	it	abstract	giv	_	_
7-52	1008-1011	and	_	_	_	_
7-53	1012-1013	,	_	_	_	_
7-54	1014-1026	consequently	_	_	_	_
7-55	1027-1028	,	_	_	_	_
7-56	1029-1032	the	abstract[56]	giv[56]	_	_
7-57	1033-1035	pH	abstract[56]	giv[56]	_	_
7-58	1036-1045	decreases	_	_	_	_
7-59	1046-1047	.	_	_	_	_

#Text=Hutton and Chehak described the “ Wisconsin process ” ( lactic acid starter culture combined with sucrose ) as a similar method to be applied in bacon with a reduced content of nitrite .
8-1	1048-1054	Hutton	person	new	_	_
8-2	1055-1058	and	_	_	_	_
8-3	1059-1065	Chehak	person	new	_	_
8-4	1066-1075	described	_	_	_	_
8-5	1076-1079	the	abstract[60]	new[60]	appos	8-11[64_60]
8-6	1080-1081	“	abstract[60]	new[60]	_	_
8-7	1082-1091	Wisconsin	place|abstract[60]	new|new[60]	_	_
8-8	1092-1099	process	abstract[60]	new[60]	_	_
8-9	1100-1101	”	abstract[60]	new[60]	_	_
8-10	1102-1103	(	_	_	_	_
8-11	1104-1110	lactic	abstract|abstract[64]	new|giv[64]	coref	12-2
8-12	1111-1115	acid	substance|abstract[64]	giv|giv[64]	coref	9-38[80_0]
8-13	1116-1123	starter	abstract|abstract[64]	new|giv[64]	coref	24-5
8-14	1124-1131	culture	abstract[64]	giv[64]	_	_
8-15	1132-1140	combined	_	_	_	_
8-16	1141-1145	with	_	_	_	_
8-17	1146-1153	sucrose	substance	new	_	_
8-18	1154-1155	)	_	_	_	_
8-19	1156-1158	as	_	_	_	_
8-20	1159-1160	a	_	_	_	_
8-21	1161-1168	similar	_	_	_	_
8-22	1169-1175	method	_	_	_	_
8-23	1176-1178	to	_	_	_	_
8-24	1179-1181	be	_	_	_	_
8-25	1182-1189	applied	_	_	_	_
8-26	1190-1192	in	_	_	_	_
8-27	1193-1198	bacon	substance	new	_	_
8-28	1199-1203	with	_	_	_	_
8-29	1204-1205	a	substance[67]	new[67]	_	_
8-30	1206-1213	reduced	substance[67]	new[67]	_	_
8-31	1214-1221	content	substance[67]	new[67]	_	_
8-32	1222-1224	of	substance[67]	new[67]	_	_
8-33	1225-1232	nitrite	substance[67]|substance	new[67]|new	_	_
8-34	1233-1234	.	_	_	_	_

#Text=These authors also found a similar effect with the combination of Pediococcus acidilactici plus dextrose in chicken salad ; it was interesting to report that conditions of abuse temperature were the most effective for the production of acid by P. acidilactici after the use of dextrose .
9-1	1235-1240	These	person[69]	new[69]	_	_
9-2	1241-1248	authors	person[69]	new[69]	_	_
9-3	1249-1253	also	_	_	_	_
9-4	1254-1259	found	_	_	_	_
9-5	1260-1261	a	abstract[70]	new[70]	_	_
9-6	1262-1269	similar	abstract[70]	new[70]	_	_
9-7	1270-1276	effect	abstract[70]	new[70]	_	_
9-8	1277-1281	with	abstract[70]	new[70]	_	_
9-9	1282-1285	the	abstract[70]|abstract[71]	new[70]|new[71]	ana	9-20[0_71]
9-10	1286-1297	combination	abstract[70]|abstract[71]	new[70]|new[71]	_	_
9-11	1298-1300	of	abstract[70]|abstract[71]	new[70]|new[71]	_	_
9-12	1301-1312	Pediococcus	abstract[70]|abstract[71]	new[70]|new[71]	_	_
9-13	1313-1325	acidilactici	abstract[70]|abstract[71]	new[70]|new[71]	_	_
9-14	1326-1330	plus	abstract[70]|abstract[71]	new[70]|new[71]	_	_
9-15	1331-1339	dextrose	abstract[70]|abstract[71]|substance[72]	new[70]|new[71]|new[72]	coref	9-46[0_72]
9-16	1340-1342	in	abstract[70]|abstract[71]|substance[72]	new[70]|new[71]|new[72]	_	_
9-17	1343-1350	chicken	abstract[70]|abstract[71]|substance[72]|animal|substance[74]	new[70]|new[71]|new[72]|new|new[74]	coref	20-16[0_74]
9-18	1351-1356	salad	abstract[70]|abstract[71]|substance[72]|substance[74]	new[70]|new[71]|new[72]|new[74]	_	_
9-19	1357-1358	;	_	_	_	_
9-20	1359-1361	it	abstract	giv	_	_
9-21	1362-1365	was	_	_	_	_
9-22	1366-1377	interesting	_	_	_	_
9-23	1378-1380	to	_	_	_	_
9-24	1381-1387	report	_	_	_	_
9-25	1388-1392	that	_	_	_	_
9-26	1393-1403	conditions	abstract[76]	giv[76]	_	_
9-27	1404-1406	of	abstract[76]	giv[76]	_	_
9-28	1407-1412	abuse	abstract[76]|event|abstract[78]	giv[76]|giv|new[78]	_	_
9-29	1413-1424	temperature	abstract[76]|abstract[78]	giv[76]|new[78]	_	_
9-30	1425-1429	were	_	_	_	_
9-31	1430-1433	the	_	_	_	_
9-32	1434-1438	most	_	_	_	_
9-33	1439-1448	effective	_	_	_	_
9-34	1449-1452	for	_	_	_	_
9-35	1453-1456	the	event[79]	new[79]	_	_
9-36	1457-1467	production	event[79]	new[79]	_	_
9-37	1468-1470	of	event[79]	new[79]	_	_
9-38	1471-1475	acid	event[79]|substance[80]	new[79]|giv[80]	_	_
9-39	1476-1478	by	event[79]|substance[80]	new[79]|giv[80]	_	_
9-40	1479-1481	P.	event[79]|substance[80]|place[81]	new[79]|giv[80]|new[81]	_	_
9-41	1482-1494	acidilactici	event[79]|substance[80]|place[81]	new[79]|giv[80]|new[81]	_	_
9-42	1495-1500	after	_	_	_	_
9-43	1501-1504	the	event[82]	new[82]	_	_
9-44	1505-1508	use	event[82]	new[82]	_	_
9-45	1509-1511	of	event[82]	new[82]	_	_
9-46	1512-1520	dextrose	event[82]|substance	new[82]|giv	_	_
9-47	1521-1522	.	_	_	_	_

#Text=4.2 .
10-1	1523-1526	4.2	abstract	new	_	_
10-2	1527-1528	.	_	_	_	_

#Text=Bacteriocins
11-1	1529-1541	Bacteriocins	abstract	new	_	_

#Text=Some lactic acid bacteria produce ribosomally synthesized peptides , called bacteriocins , with antimicrobial capacity that are not lethal to the host ; these proteins inhibit both pathogenic and spoilage bacteria without changing the physicochemical characteristics of the food , that is , the inhibition is not exerted by acidification , protein denaturation , or other processes .
12-1	1542-1546	Some	substance[87]	giv[87]	coref	12-30[95_87]
12-2	1547-1553	lactic	abstract|substance[87]	giv|giv[87]	_	_
12-3	1554-1558	acid	substance[87]	giv[87]	_	_
12-4	1559-1567	bacteria	substance[87]	giv[87]	_	_
12-5	1568-1575	produce	_	_	_	_
12-6	1576-1587	ribosomally	object[88]	new[88]	_	_
12-7	1588-1599	synthesized	object[88]	new[88]	_	_
12-8	1600-1608	peptides	object[88]	new[88]	_	_
12-9	1609-1610	,	_	_	_	_
12-10	1611-1617	called	_	_	_	_
12-11	1618-1630	bacteriocins	substance[89]	new[89]	coref	13-4[104_89]
12-12	1631-1632	,	substance[89]	new[89]	_	_
12-13	1633-1637	with	substance[89]	new[89]	_	_
12-14	1638-1651	antimicrobial	substance[89]|abstract[90]	new[89]|new[90]	coref	24-9[205_90]
12-15	1652-1660	capacity	substance[89]|abstract[90]	new[89]|new[90]	_	_
12-16	1661-1665	that	_	_	_	_
12-17	1666-1669	are	_	_	_	_
12-18	1670-1673	not	_	_	_	_
12-19	1674-1680	lethal	_	_	_	_
12-20	1681-1683	to	_	_	_	_
12-21	1684-1687	the	person[91]	new[91]	_	_
12-22	1688-1692	host	person[91]	new[91]	_	_
12-23	1693-1694	;	_	_	_	_
12-24	1695-1700	these	object[92]	new[92]	_	_
12-25	1701-1709	proteins	object[92]	new[92]	_	_
12-26	1710-1717	inhibit	_	_	_	_
12-27	1718-1722	both	abstract[93]	new[93]	coref	17-25[143_93]
12-28	1723-1733	pathogenic	abstract[93]	new[93]	_	_
12-29	1734-1737	and	_	_	_	_
12-30	1738-1746	spoilage	abstract|substance[95]	new|giv[95]	coref	15-1[121_95]
12-31	1747-1755	bacteria	substance[95]	giv[95]	_	_
12-32	1756-1763	without	_	_	_	_
12-33	1764-1772	changing	_	_	_	_
12-34	1773-1776	the	abstract[96]	new[96]	_	_
12-35	1777-1792	physicochemical	abstract[96]	new[96]	_	_
12-36	1793-1808	characteristics	abstract[96]	new[96]	_	_
12-37	1809-1811	of	abstract[96]	new[96]	_	_
12-38	1812-1815	the	abstract[96]|substance[97]	new[96]|giv[97]	coref	14-14[0_97]
12-39	1816-1820	food	abstract[96]|substance[97]	new[96]|giv[97]	_	_
12-40	1821-1822	,	_	_	_	_
12-41	1823-1827	that	_	_	_	_
12-42	1828-1830	is	_	_	_	_
12-43	1831-1832	,	_	_	_	_
12-44	1833-1836	the	abstract[98]	new[98]	_	_
12-45	1837-1847	inhibition	abstract[98]	new[98]	_	_
12-46	1848-1850	is	_	_	_	_
12-47	1851-1854	not	_	_	_	_
12-48	1855-1862	exerted	_	_	_	_
12-49	1863-1865	by	_	_	_	_
12-50	1866-1879	acidification	substance	giv	_	_
12-51	1880-1881	,	_	_	_	_
12-52	1882-1889	protein	substance|abstract[101]	new|new[101]	_	_
12-53	1890-1902	denaturation	abstract[101]	new[101]	_	_
12-54	1903-1904	,	_	_	_	_
12-55	1905-1907	or	_	_	_	_
12-56	1908-1913	other	abstract[102]	new[102]	_	_
12-57	1914-1923	processes	abstract[102]	new[102]	_	_
12-58	1924-1925	.	_	_	_	_

#Text=The interest in LAB-produced bacteriocins has grown dramatically because of their antimicrobial capacities and the use of LAB as starter cultures .
13-1	1926-1929	The	abstract[103]	new[103]	_	_
13-2	1930-1938	interest	abstract[103]	new[103]	_	_
13-3	1939-1941	in	abstract[103]	new[103]	_	_
13-4	1942-1954	LAB-produced	abstract[103]|substance[104]	new[103]|giv[104]	ana	13-11[0_104]
13-5	1955-1967	bacteriocins	abstract[103]|substance[104]	new[103]|giv[104]	_	_
13-6	1968-1971	has	_	_	_	_
13-7	1972-1977	grown	_	_	_	_
13-8	1978-1990	dramatically	_	_	_	_
13-9	1991-1998	because	_	_	_	_
13-10	1999-2001	of	_	_	_	_
13-11	2002-2007	their	substance|abstract[106]	giv|new[106]	coref	14-4
13-12	2008-2021	antimicrobial	abstract[106]	new[106]	_	_
13-13	2022-2032	capacities	abstract[106]	new[106]	_	_
13-14	2033-2036	and	_	_	_	_
13-15	2037-2040	the	abstract[107]	new[107]	_	_
13-16	2041-2044	use	abstract[107]	new[107]	_	_
13-17	2045-2047	of	abstract[107]	new[107]	_	_
13-18	2048-2051	LAB	abstract[107]|object[108]	new[107]|giv[108]	coref	14-6[112_108]
13-19	2052-2054	as	abstract[107]|object[108]	new[107]|giv[108]	_	_
13-20	2055-2062	starter	abstract[107]|object[108]	new[107]|giv[108]	_	_
13-21	2063-2071	cultures	abstract[107]|object[108]	new[107]|giv[108]	_	_
13-22	2072-2073	.	_	_	_	_

#Text=The use of bacteriocins or bacteriocinogenic LAB or both is important to the food industry because of the demand for natural products by consumers that are also increasing concern about foodborne pathogens .
14-1	2074-2077	The	abstract[109]	new[109]	_	_
14-2	2078-2081	use	abstract[109]	new[109]	_	_
14-3	2082-2084	of	abstract[109]	new[109]	_	_
14-4	2085-2097	bacteriocins	abstract[109]|substance	new[109]|giv	coref	15-6[122_0]
14-5	2098-2100	or	abstract[109]	new[109]	_	_
14-6	2101-2118	bacteriocinogenic	abstract[109]|abstract|object[112]	new[109]|new|giv[112]	_	_
14-7	2119-2122	LAB	abstract[109]|object[112]	new[109]|giv[112]	_	_
14-8	2123-2125	or	abstract[109]	new[109]	_	_
14-9	2126-2130	both	abstract[109]	new[109]	_	_
14-10	2131-2133	is	_	_	_	_
14-11	2134-2143	important	_	_	_	_
14-12	2144-2146	to	_	_	_	_
14-13	2147-2150	the	abstract[114]	new[114]	_	_
14-14	2151-2155	food	substance|abstract[114]	giv|new[114]	coref	19-13
14-15	2156-2164	industry	abstract[114]	new[114]	_	_
14-16	2165-2172	because	_	_	_	_
14-17	2173-2175	of	_	_	_	_
14-18	2176-2179	the	abstract[115]	new[115]	_	_
14-19	2180-2186	demand	abstract[115]	new[115]	_	_
14-20	2187-2190	for	abstract[115]	new[115]	_	_
14-21	2191-2198	natural	abstract[115]|abstract[116]	new[115]|new[116]	_	_
14-22	2199-2207	products	abstract[115]|abstract[116]	new[115]|new[116]	_	_
14-23	2208-2210	by	abstract[115]|abstract[116]	new[115]|new[116]	_	_
14-24	2211-2220	consumers	abstract[115]|abstract[116]|person	new[115]|new[116]|new	_	_
14-25	2221-2225	that	_	_	_	_
14-26	2226-2229	are	_	_	_	_
14-27	2230-2234	also	_	_	_	_
14-28	2235-2245	increasing	_	_	_	_
14-29	2246-2253	concern	abstract	new	_	_
14-30	2254-2259	about	_	_	_	_
14-31	2260-2269	foodborne	abstract|abstract[120]	new|giv[120]	coref	23-11
14-32	2270-2279	pathogens	abstract[120]	giv[120]	_	_
14-33	2280-2281	.	_	_	_	_

#Text=Gram-positive bacteria are inhibited by most bacteriocins .
15-1	2282-2295	Gram-positive	substance[121]	giv[121]	coref	16-1[123_121]
15-2	2296-2304	bacteria	substance[121]	giv[121]	_	_
15-3	2305-2308	are	_	_	_	_
15-4	2309-2318	inhibited	_	_	_	_
15-5	2319-2321	by	_	_	_	_
15-6	2322-2326	most	substance[122]	giv[122]	coref	16-8[124_122]
15-7	2327-2339	bacteriocins	substance[122]	giv[122]	_	_
15-8	2340-2341	.	_	_	_	_

#Text=Gram-negative bacteria can be increasingly sensitive to bacteriocins after the use of chelating agents or hydrostatic pressure ; these techniques can also be synergic enhancing the action of bacteriocins against Gram-positive bacteria , or even with the use of nanoparticles or nanovesicles .
16-1	2342-2355	Gram-negative	substance[123]	giv[123]	coref	16-31[132_123]
16-2	2356-2364	bacteria	substance[123]	giv[123]	_	_
16-3	2365-2368	can	_	_	_	_
16-4	2369-2371	be	_	_	_	_
16-5	2372-2384	increasingly	_	_	_	_
16-6	2385-2394	sensitive	_	_	_	_
16-7	2395-2397	to	_	_	_	_
16-8	2398-2410	bacteriocins	substance[124]	giv[124]	coref	16-29[131_124]
16-9	2411-2416	after	substance[124]	giv[124]	_	_
16-10	2417-2420	the	substance[124]|abstract[125]	giv[124]|new[125]	_	_
16-11	2421-2424	use	substance[124]|abstract[125]	giv[124]|new[125]	_	_
16-12	2425-2427	of	substance[124]|abstract[125]	giv[124]|new[125]	_	_
16-13	2428-2437	chelating	substance[124]|abstract[125]|person|substance[127]	giv[124]|new[125]|new|new[127]	_	_
16-14	2438-2444	agents	substance[124]|abstract[125]|substance[127]	giv[124]|new[125]|new[127]	_	_
16-15	2445-2447	or	substance[124]|abstract[125]	giv[124]|new[125]	_	_
16-16	2448-2459	hydrostatic	substance[124]|abstract[125]|abstract[128]	giv[124]|new[125]|new[128]	_	_
16-17	2460-2468	pressure	substance[124]|abstract[125]|abstract[128]	giv[124]|new[125]|new[128]	_	_
16-18	2469-2470	;	_	_	_	_
16-19	2471-2476	these	abstract[129]	new[129]	_	_
16-20	2477-2487	techniques	abstract[129]	new[129]	_	_
16-21	2488-2491	can	_	_	_	_
16-22	2492-2496	also	_	_	_	_
16-23	2497-2499	be	_	_	_	_
16-24	2500-2508	synergic	_	_	_	_
16-25	2509-2518	enhancing	_	_	_	_
16-26	2519-2522	the	abstract[130]	new[130]	_	_
16-27	2523-2529	action	abstract[130]	new[130]	_	_
16-28	2530-2532	of	abstract[130]	new[130]	_	_
16-29	2533-2545	bacteriocins	abstract[130]|substance[131]	new[130]|giv[131]	coref	17-1[0_131]
16-30	2546-2553	against	abstract[130]|substance[131]	new[130]|giv[131]	_	_
16-31	2554-2567	Gram-positive	abstract[130]|substance[131]|substance[132]	new[130]|giv[131]|giv[132]	coref	17-28[144_132]
16-32	2568-2576	bacteria	abstract[130]|substance[131]|substance[132]	new[130]|giv[131]|giv[132]	_	_
16-33	2577-2578	,	_	_	_	_
16-34	2579-2581	or	_	_	_	_
16-35	2582-2586	even	abstract[133]	new[133]	ana	17-12[0_133]
16-36	2587-2591	with	abstract[133]	new[133]	_	_
16-37	2592-2595	the	abstract[133]	new[133]	_	_
16-38	2596-2599	use	abstract[133]	new[133]	_	_
16-39	2600-2602	of	abstract[133]	new[133]	_	_
16-40	2603-2616	nanoparticles	abstract[133]|object	new[133]|new	_	_
16-41	2617-2619	or	abstract[133]	new[133]	_	_
16-42	2620-2632	nanovesicles	abstract[133]|object	new[133]|new	_	_
16-43	2633-2634	.	_	_	_	_

#Text=Bacteriocins can be used in different ways in foods : ( i ) They can be directly added to foods inhibiting the growth of both pathogenic and spoilage bacteria ; nisin is the only bacteriocin commercially available .
17-1	2635-2647	Bacteriocins	substance	giv	_	_
17-2	2648-2651	can	_	_	_	_
17-3	2652-2654	be	_	_	_	_
17-4	2655-2659	used	_	_	_	_
17-5	2660-2662	in	_	_	_	_
17-6	2663-2672	different	abstract[137]	new[137]	ana	17-14[0_137]
17-7	2673-2677	ways	abstract[137]	new[137]	_	_
17-8	2678-2680	in	abstract[137]	new[137]	_	_
17-9	2681-2686	foods	abstract[137]|substance	new[137]|giv	coref	17-20
17-10	2687-2688	:	_	_	_	_
17-11	2689-2690	(	_	_	_	_
17-12	2691-2692	i	abstract	giv	_	_
17-13	2693-2694	)	_	_	_	_
17-14	2695-2699	They	abstract	giv	_	_
17-15	2700-2703	can	_	_	_	_
17-16	2704-2706	be	_	_	_	_
17-17	2707-2715	directly	_	_	_	_
17-18	2716-2721	added	_	_	_	_
17-19	2722-2724	to	_	_	_	_
17-20	2725-2730	foods	substance	giv	coref	18-9[150_0]
17-21	2731-2741	inhibiting	_	_	_	_
17-22	2742-2745	the	abstract[142]	giv[142]	ana	19-1[0_142]
17-23	2746-2752	growth	abstract[142]	giv[142]	_	_
17-24	2753-2755	of	abstract[142]	giv[142]	_	_
17-25	2756-2760	both	abstract[142]|abstract[143]	giv[142]|giv[143]	_	_
17-26	2761-2771	pathogenic	abstract[142]|abstract[143]	giv[142]|giv[143]	_	_
17-27	2772-2775	and	abstract[142]	giv[142]	_	_
17-28	2776-2784	spoilage	abstract[142]|substance[144]	giv[142]|giv[144]	coref	21-11[176_144]
17-29	2785-2793	bacteria	abstract[142]|substance[144]	giv[142]|giv[144]	_	_
17-30	2794-2795	;	_	_	_	_
17-31	2796-2801	nisin	substance	new	coref	17-33[146_0]
17-32	2802-2804	is	_	_	_	_
17-33	2805-2808	the	substance[146]	giv[146]	coref	18-1[0_146]
17-34	2809-2813	only	substance[146]	giv[146]	_	_
17-35	2814-2825	bacteriocin	substance[146]	giv[146]	_	_
17-36	2826-2838	commercially	substance[146]	giv[146]	_	_
17-37	2839-2848	available	substance[146]	giv[146]	_	_
17-38	2849-2850	.	_	_	_	_

#Text=Nisin is added to milk , cheese , canned foods , mayonnaise , and other foods .
18-1	2851-2856	Nisin	substance	giv	_	_
18-2	2857-2859	is	_	_	_	_
18-3	2860-2865	added	_	_	_	_
18-4	2866-2868	to	_	_	_	_
18-5	2869-2873	milk	substance	new	_	_
18-6	2874-2875	,	_	_	_	_
18-7	2876-2882	cheese	substance	new	coref	20-21
18-8	2883-2884	,	_	_	_	_
18-9	2885-2891	canned	substance[150]	giv[150]	coref	18-15[152_150]
18-10	2892-2897	foods	substance[150]	giv[150]	_	_
18-11	2898-2899	,	_	_	_	_
18-12	2900-2910	mayonnaise	substance	new	_	_
18-13	2911-2912	,	_	_	_	_
18-14	2913-2916	and	_	_	_	_
18-15	2917-2922	other	substance[152]	giv[152]	coref	21-25[179_152]
18-16	2923-2928	foods	substance[152]	giv[152]	_	_
18-17	2929-2930	.	_	_	_	_

#Text=It is considered as a Generally Recognized as Safe ( GRAS ) food preservative , and once it is absorbed onto surfaces it inhibits the growth of Listeria spp. and prevents the formation of biofilms .
19-1	2931-2933	It	abstract	giv	ana	19-18
19-2	2934-2936	is	_	_	_	_
19-3	2937-2947	considered	_	_	_	_
19-4	2948-2950	as	_	_	_	_
19-5	2951-2952	a	_	_	_	_
19-6	2953-2962	Generally	_	_	_	_
19-7	2963-2973	Recognized	_	_	_	_
19-8	2974-2976	as	_	_	_	_
19-9	2977-2981	Safe	_	_	_	_
19-10	2982-2983	(	_	_	_	_
19-11	2984-2988	GRAS	person	new	_	_
19-12	2989-2990	)	_	_	_	_
19-13	2991-2995	food	substance	giv	coref	21-37
19-14	2996-3008	preservative	_	_	_	_
19-15	3009-3010	,	_	_	_	_
19-16	3011-3014	and	_	_	_	_
19-17	3015-3019	once	_	_	_	_
19-18	3020-3022	it	abstract	giv	ana	19-23
19-19	3023-3025	is	_	_	_	_
19-20	3026-3034	absorbed	_	_	_	_
19-21	3035-3039	onto	_	_	_	_
19-22	3040-3048	surfaces	object	new	ana	20-10
19-23	3049-3051	it	abstract	giv	_	_
19-24	3052-3060	inhibits	_	_	_	_
19-25	3061-3064	the	abstract[159]	new[159]	_	_
19-26	3065-3071	growth	abstract[159]	new[159]	_	_
19-27	3072-3074	of	abstract[159]	new[159]	_	_
19-28	3075-3083	Listeria	abstract[159]	new[159]	_	_
19-29	3084-3088	spp.	abstract[159]	new[159]	_	_
19-30	3089-3092	and	_	_	_	_
19-31	3093-3101	prevents	_	_	_	_
19-32	3102-3105	the	event[160]	new[160]	_	_
19-33	3106-3115	formation	event[160]	new[160]	_	_
19-34	3116-3118	of	event[160]	new[160]	_	_
19-35	3119-3127	biofilms	event[160]|substance	new[160]|new	_	_
19-36	3128-3129	.	_	_	_	_

#Text=Pediocins also inhibit the growth of L. monocytogenes and they are used in salads and salad dressings , cream , cheese and meats .
20-1	3130-3139	Pediocins	substance	new	_	_
20-2	3140-3144	also	_	_	_	_
20-3	3145-3152	inhibit	_	_	_	_
20-4	3153-3156	the	abstract[163]	new[163]	_	_
20-5	3157-3163	growth	abstract[163]	new[163]	_	_
20-6	3164-3166	of	abstract[163]	new[163]	_	_
20-7	3167-3169	L.	abstract[163]|person|place[165]	new[163]|new|new[165]	_	_
20-8	3170-3183	monocytogenes	abstract[163]|place[165]	new[163]|new[165]	_	_
20-9	3184-3187	and	_	_	_	_
20-10	3188-3192	they	object	giv	_	_
20-11	3193-3196	are	_	_	_	_
20-12	3197-3201	used	_	_	_	_
20-13	3202-3204	in	_	_	_	_
20-14	3205-3211	salads	object|abstract[168]	new|new[168]	ana	21-29[0_168]
20-15	3212-3215	and	abstract[168]	new[168]	_	_
20-16	3216-3221	salad	abstract[168]|substance|object[170]	new[168]|giv|new[170]	_	_
20-17	3222-3231	dressings	abstract[168]|object[170]	new[168]|new[170]	_	_
20-18	3232-3233	,	abstract[168]	new[168]	_	_
20-19	3234-3239	cream	abstract[168]|substance	new[168]|new	_	_
20-20	3240-3241	,	abstract[168]	new[168]	_	_
20-21	3242-3248	cheese	abstract[168]|substance	new[168]|giv	_	_
20-22	3249-3252	and	abstract[168]	new[168]	_	_
20-23	3253-3258	meats	abstract[168]|substance	new[168]|new	_	_
20-24	3259-3260	.	_	_	_	_

#Text=Reuterin is secreted by Lactobacillus reuteri and possess activity against Gram-positive and -negative pathogenic bacteria . ( ii ) To add bacteriocin-producing bacteria to non-fermented foods or use them as starter cultures for the improvement of food safety .
21-1	3261-3269	Reuterin	substance	new	_	_
21-2	3270-3272	is	_	_	_	_
21-3	3273-3281	secreted	_	_	_	_
21-4	3282-3284	by	_	_	_	_
21-5	3285-3298	Lactobacillus	_	_	_	_
21-6	3299-3306	reuteri	_	_	_	_
21-7	3307-3310	and	_	_	_	_
21-8	3311-3318	possess	_	_	_	_
21-9	3319-3327	activity	abstract[175]	new[175]	_	_
21-10	3328-3335	against	abstract[175]	new[175]	_	_
21-11	3336-3349	Gram-positive	abstract[175]|substance[176]	new[175]|giv[176]	appos	21-18[0_176]
21-12	3350-3353	and	abstract[175]|substance[176]	new[175]|giv[176]	_	_
21-13	3354-3363	-negative	abstract[175]|substance[176]	new[175]|giv[176]	_	_
21-14	3364-3374	pathogenic	abstract[175]|substance[176]	new[175]|giv[176]	_	_
21-15	3375-3383	bacteria	abstract[175]|substance[176]	new[175]|giv[176]	_	_
21-16	3384-3385	.	_	_	_	_
21-17	3386-3387	(	_	_	_	_
21-18	3388-3390	ii	substance	giv	coref	21-22[178_0]
21-19	3391-3392	)	_	_	_	_
21-20	3393-3395	To	_	_	_	_
21-21	3396-3399	add	_	_	_	_
21-22	3400-3421	bacteriocin-producing	substance[178]	giv[178]	coref	23-22[0_178]
21-23	3422-3430	bacteria	substance[178]	giv[178]	_	_
21-24	3431-3433	to	substance[178]	giv[178]	_	_
21-25	3434-3447	non-fermented	substance[178]|substance[179]	giv[178]|giv[179]	_	_
21-26	3448-3453	foods	substance[178]|substance[179]	giv[178]|giv[179]	_	_
21-27	3454-3456	or	_	_	_	_
21-28	3457-3460	use	_	_	_	_
21-29	3461-3465	them	abstract	giv	_	_
21-30	3466-3468	as	_	_	_	_
21-31	3469-3476	starter	_	_	_	_
21-32	3477-3485	cultures	_	_	_	_
21-33	3486-3489	for	_	_	_	_
21-34	3490-3493	the	abstract[181]	new[181]	_	_
21-35	3494-3505	improvement	abstract[181]	new[181]	_	_
21-36	3506-3508	of	abstract[181]	new[181]	_	_
21-37	3509-3513	food	abstract[181]|substance|abstract[183]	new[181]|giv|new[183]	_	_
21-38	3514-3520	safety	abstract[181]|abstract[183]	new[181]|new[183]	_	_
21-39	3521-3522	.	_	_	_	_

#Text=For a fine description see Montville and Chikindas .
22-1	3523-3526	For	_	_	_	_
22-2	3527-3528	a	abstract[184]	new[184]	_	_
22-3	3529-3533	fine	abstract[184]	new[184]	_	_
22-4	3534-3545	description	abstract[184]	new[184]	_	_
22-5	3546-3549	see	_	_	_	_
22-6	3550-3559	Montville	person	new	_	_
22-7	3560-3563	and	_	_	_	_
22-8	3564-3573	Chikindas	place	new	_	_
22-9	3574-3575	.	_	_	_	_

#Text=Natamycin is produced by fermentation using Streptomyces spp. acting against foodborne moulds and yeasts ; however , it is inactive against bacteria and viruses . ( iii ) A third way is to use bacteriocin-producing bacteria as starter cultures to direct the fermentation .
23-1	3576-3585	Natamycin	substance	new	_	_
23-2	3586-3588	is	_	_	_	_
23-3	3589-3597	produced	_	_	_	_
23-4	3598-3600	by	_	_	_	_
23-5	3601-3613	fermentation	substance	new	ana	23-18
23-6	3614-3619	using	_	_	_	_
23-7	3620-3632	Streptomyces	abstract|object[190]	new|new[190]	_	_
23-8	3633-3637	spp.	object[190]	new[190]	_	_
23-9	3638-3644	acting	_	_	_	_
23-10	3645-3652	against	_	_	_	_
23-11	3653-3662	foodborne	place|abstract[192]	giv|new[192]	_	_
23-12	3663-3669	moulds	abstract[192]	new[192]	_	_
23-13	3670-3673	and	_	_	_	_
23-14	3674-3680	yeasts	substance	new	_	_
23-15	3681-3682	;	_	_	_	_
23-16	3683-3690	however	_	_	_	_
23-17	3691-3692	,	_	_	_	_
23-18	3693-3695	it	substance	giv	coref	23-42[200_0]
23-19	3696-3698	is	_	_	_	_
23-20	3699-3707	inactive	_	_	_	_
23-21	3708-3715	against	_	_	_	_
23-22	3716-3724	bacteria	substance|abstract[196]	giv|giv[196]	coref|ana	23-35[199_0]|24-9[0_196]
23-23	3725-3728	and	abstract[196]	giv[196]	_	_
23-24	3729-3736	viruses	abstract[196]|place	giv[196]|new	_	_
23-25	3737-3738	.	_	_	_	_
23-26	3739-3740	(	_	_	_	_
23-27	3741-3744	iii	_	_	_	_
23-28	3745-3746	)	_	_	_	_
23-29	3747-3748	A	abstract[198]	new[198]	_	_
23-30	3749-3754	third	abstract[198]	new[198]	_	_
23-31	3755-3758	way	abstract[198]	new[198]	_	_
23-32	3759-3761	is	_	_	_	_
23-33	3762-3764	to	_	_	_	_
23-34	3765-3768	use	_	_	_	_
23-35	3769-3790	bacteriocin-producing	substance[199]	giv[199]	_	_
23-36	3791-3799	bacteria	substance[199]	giv[199]	_	_
23-37	3800-3802	as	substance[199]	giv[199]	_	_
23-38	3803-3810	starter	substance[199]	giv[199]	_	_
23-39	3811-3819	cultures	substance[199]	giv[199]	_	_
23-40	3820-3822	to	_	_	_	_
23-41	3823-3829	direct	_	_	_	_
23-42	3830-3833	the	substance[200]	giv[200]	_	_
23-43	3834-3846	fermentation	substance[200]	giv[200]	_	_
23-44	3847-3848	.	_	_	_	_

#Text=The benefits of defined starter cultures depend on their capacity to predominate over the indigenous microbiota .
24-1	3849-3852	The	abstract[201]	new[201]	_	_
24-2	3853-3861	benefits	abstract[201]	new[201]	_	_
24-3	3862-3864	of	abstract[201]	new[201]	_	_
24-4	3865-3872	defined	abstract[201]|object[203]	new[201]|new[203]	_	_
24-5	3873-3880	starter	abstract[201]|abstract|object[203]	new[201]|giv|new[203]	_	_
24-6	3881-3889	cultures	abstract[201]|object[203]	new[201]|new[203]	_	_
24-7	3890-3896	depend	_	_	_	_
24-8	3897-3899	on	_	_	_	_
24-9	3900-3905	their	abstract|abstract[205]	giv|giv[205]	_	_
24-10	3906-3914	capacity	abstract[205]	giv[205]	_	_
24-11	3915-3917	to	_	_	_	_
24-12	3918-3929	predominate	_	_	_	_
24-13	3930-3934	over	_	_	_	_
24-14	3935-3938	the	abstract[206]	new[206]	_	_
24-15	3939-3949	indigenous	abstract[206]	new[206]	_	_
24-16	3950-3960	microbiota	abstract[206]	new[206]	_	_
24-17	3961-3962	.	_	_	_	_
